Comparable stake leader
BlackRock, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000914208.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
MASSACHUSETTS MUTUAL LIFE INSURANCE CO
Comparable rows
50/50
Latest evidence
15 May 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
8.1%
from 13D/G
|
$941,184,574
38,747,821 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.2%
|
$770,986,801
31,740,914 shares
|
$0 | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
Company
|
4.9%
|
$573,959,727
21,848,486 shares
|
-$113,186,055 | 31 Dec 2025 |
| TRIAN FUND MANAGEMENT, L.P. |
3/4/5
13D/G
13F
10%+ Owner · Nelson Peltz · Company
|
4.6%
from 13D/G
|
$723,073,473
45,419,188 shares
|
— | 27 Jan 2023 |
| G. Richard Wagoner Jr. |
3/4/5
Director
|
0.03%
|
$2,984,512
122,870 shares
|
— | 15 May 2026 |
| Sarah Beshar |
3/4/5
Director
|
0.03%
|
$2,797,381
115,166 shares
|
— | 15 May 2026 |
| Phoebe A. Wood |
3/4/5
Director
|
0.02%
|
$2,674,600
110,111 shares
|
— | 15 May 2026 |
| Nigel Sheinwald |
3/4/5
Director
|
0.02%
|
$2,476,802
101,968 shares
|
— | 15 May 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$6,051,542.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 160,000 | $0 | $3,768,832 | -$3,768,832 |
| 9-12 | 0 | 103,192 | $0 | $2,282,710 | -$2,282,710 |
Reporting owners
Showing 1-20 of 34 reporting-owner rows connected to Invesco Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| MM Asset Management Holding LLC | 10%+ Owner | $1,294,810,518 | Mixed | 13 Jun 2022 | ||
| MASSACHUSETTS MUTUAL LIFE INSURANCE CO | 10%+ Owner | $1,268,460,053 | Mixed | 01 Nov 2021 | ||
| Nelson Peltz | Director | $723,813,037 | Mixed | 13 Dec 2021 | ||
| Edward P. Garden | Director | $723,813,037 | Mixed | 13 Dec 2021 | ||
| TRIAN FUND MANAGEMENT, L.P. | 10%+ Owner | $723,073,473 | Mixed | 27 Jan 2023 | ||
| Martin L. Flanagan | President & CEO, Director | $64,108,964 | Mixed | 28 Feb 2023 | ||
| Andrew Schlossberg | President and CEO, Director | $23,600,255 | Mixed | 28 Feb 2026 | ||
| Andrew Tak Shing Lo | Senior Managing Director | $22,521,256 | Mixed | 28 Feb 2026 | ||
| Kevin M. Carome | SMD and General Counsel | $9,965,872 | Mixed | 28 Feb 2022 | ||
| Laura Allison Dukes | Chief Financial Officer | $8,987,773 | Mixed | 28 Feb 2026 | ||
| Gregory McGreevey | Senior Managing Director | $4,145,616 | Mixed | 08 Mar 2022 | ||
| Jeffrey H. Kupor | Senior Managing Director | $3,986,793 | Mixed | 28 Feb 2026 | ||
| Tony Wong | Senior Managing Director | $3,334,258 | Mixed | 28 Feb 2026 | ||
| G. Richard Wagoner Jr. | Director | $2,984,512 | Median | 15 May 2026 | ||
| Sarah Beshar | Director | $2,797,381 | Median | 15 May 2026 | ||
| Mark F. Giuliano | SMD & Chief Adm Officer | $2,730,442 | Mixed | 28 Feb 2024 | ||
| Phoebe A. Wood | Director | $2,674,600 | Median | 15 May 2026 | ||
| Nigel Sheinwald | Director | $2,476,802 | Median | 15 May 2026 | ||
| Colin Meadows | Senior Managing Director | $2,164,117 | Mixed | 04 Nov 2021 | ||
| William Francis Glavin Jr. | Director | $1,969,530 | Median | 15 May 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Phoebe A. Wood | IVZ | Common Shares | Award | 7.95% | 8,112 | 110,111 | 15 May 2026 | Direct | ||
| Christopher C. Womack | IVZ | Common Shares | Award | 15.7% | 8,112 | 59,917 | 15 May 2026 | Direct | ||
| G. Richard Wagoner Jr. | IVZ | Common Shares | Award | 8.13% | 8,112 | 107,870 | 15 May 2026 | Direct | ||
| Paula Tolliver | IVZ | Common Shares | Award | 14% | 8,112 | 66,273 | 15 May 2026 | Direct | ||
| Nigel Sheinwald | IVZ | Common Shares | Award | 8.64% | 8,112 | 101,968 | 15 May 2026 | Direct | ||
| Elizabeth S. Johnson | IVZ | Common Shares | Award | 20% | 8,112 | 48,770 | 15 May 2026 | Direct | ||
| William Francis Glavin Jr. | IVZ | Common Shares | Award | 11.1% | 8,112 | 81,084 | 15 May 2026 | Direct | ||
| Thomas P. Gibbons | IVZ | Common Shares | Award | 20.8% | 8,112 | 47,202 | 15 May 2026 | Direct | ||
| Thomas M. Finke | IVZ | Common Shares | Award | 14.4% | 8,112 | 64,238 | 15 May 2026 | Direct | ||
| Sarah Beshar | IVZ | Common Shares | Award | 7.58% | 8,112 | 115,166 | 15 May 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Common Shares | Tax liability | -21% | -3,849 | 14,489 | 13 Mar 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Common Shares | Award | 89.1% | 8,641 | 18,338 | 13 Mar 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Restricted Stock Units | Options Exercise | -50% | -8,641 | 8,641 | 13 Mar 2026 | Direct | ||
| Terry Vacheron | IVZ | Common Shares | Tax liability | -12.7% | -2,852 | 19,569 | 28 Feb 2026 | Direct | ||
| Terry Vacheron | IVZ | Common Shares | Award | 27.2% | 4,798 | 22,421 | 28 Feb 2026 | Direct | ||
| Terry Vacheron | IVZ | Restricted Stock Units | Award | 8,187 | 8,187 | 28 Feb 2026 | Direct | |||
| Terry Vacheron | IVZ | Restricted Stock Units | Options Exercise | -48.6% | -4,798 | 5,069 | 28 Feb 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Common Shares | Tax liability | -29.3% | -4,014 | 9,697 | 28 Feb 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Common Shares | Award | 187.1% | 8,936 | 13,711 | 28 Feb 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Restricted Stock Units | Award | 32,202 | 32,202 | 28 Feb 2026 | Direct | |||
| Alan Leonard Smith | IVZ | Restricted Stock Units | Options Exercise | -25% | -8,936 | 26,808 | 28 Feb 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Common Shares | Tax liability | -35.1% | -21,685 | 40,115 | 28 Feb 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Common Shares | Award | 294.6% | 46,138 | 61,800 | 28 Feb 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Restricted Stock Units | Award | 80,969 | 80,969 | 28 Feb 2026 | Direct | |||
| Andrew Schlossberg | IVZ | Common Shares | Tax liability | -9.47% | -94,002 | 898,715 | 28 Feb 2026 | Direct | ||
| Andrew Schlossberg | IVZ | Common Shares | Award | 21.9% | 178,634 | 992,717 | 28 Feb 2026 | Direct | ||
| Andrew Schlossberg | IVZ | Restricted Stock Units | Award | 189,127 | 189,127 | 28 Feb 2026 | Direct | |||
| Andrew Schlossberg | IVZ | Restricted Stock Units | Options Exercise | -53.3% | -97,664 | 85,497 | 28 Feb 2026 | Direct | ||
| Andrew Tak Shing Lo | IVZ | Common Shares | Award | 21.8% | 150,267 | 839,093 | 28 Feb 2026 | Direct | ||
| Andrew Tak Shing Lo | IVZ | Restricted Stock Units | Award | 77,370 | 77,370 | 28 Feb 2026 | Direct | |||
| Andrew Tak Shing Lo | IVZ | Restricted Stock Units | Options Exercise | -100% | -66,848 | 0 | 28 Feb 2026 | Direct | ||
| Jeffrey H. Kupor | IVZ | Common Shares | Tax liability | -4.49% | -7,130 | 151,820 | 28 Feb 2026 | Direct | ||
| Jeffrey H. Kupor | IVZ | Common Shares | Award | 7.54% | 11,143 | 158,950 | 28 Feb 2026 | Direct | ||
| Jeffrey H. Kupor | IVZ | Restricted Stock Units | Award | 35,343 | 35,343 | 28 Feb 2026 | Direct | |||
| Jeffrey H. Kupor | IVZ | Restricted Stock Units | Options Exercise | -52.7% | -11,143 | 10,007 | 28 Feb 2026 | Direct | ||
| Shannon A. Johnston | IVZ | Common Shares | Tax liability | -13.8% | -3,970 | 24,846 | 28 Feb 2026 | Direct | ||
| Shannon A. Johnston | IVZ | Common Shares | Award | 44.8% | 8,913 | 28,816 | 28 Feb 2026 | Direct | ||
| Shannon A. Johnston | IVZ | Restricted Stock Units | Award | 37,825 | 37,825 | 28 Feb 2026 | Direct | |||
| Shannon A. Johnston | IVZ | Restricted Stock Units | Options Exercise | -25% | -8,913 | 26,739 | 28 Feb 2026 | Direct | ||
| Laura Allison Dukes | IVZ | Common Shares | Tax liability | -14.5% | -58,064 | 342,261 | 28 Feb 2026 | Direct | ||
| Laura Allison Dukes | IVZ | Common Shares | Award | 36.6% | 107,152 | 400,325 | 28 Feb 2026 | Direct | ||
| Laura Allison Dukes | IVZ | Restricted Stock Units | Award | 73,257 | 73,257 | 28 Feb 2026 | Direct | |||
| Laura Allison Dukes | IVZ | Restricted Stock Units | Options Exercise | -55.5% | -44,021 | 35,317 | 28 Feb 2026 | Direct | ||
| Stephanie Butcher | IVZ | Common Shares | Tax liability | -30.9% | -9,237 | 20,618 | 28 Feb 2026 | Direct | ||
| Stephanie Butcher | IVZ | Restricted Stock Units | Award | 66,317 | 66,317 | 28 Feb 2026 | Direct | |||
| Tony Wong | IVZ | Common Shares | Tax liability | -12.3% | -17,854 | 126,971 | 28 Feb 2026 | Direct | ||
| Tony Wong | IVZ | Common Shares | Award | 28.3% | 31,955 | 144,825 | 28 Feb 2026 | Direct | ||
| Tony Wong | IVZ | Restricted Stock Units | Award | 66,317 | 66,317 | 28 Feb 2026 | Direct | |||
| Tony Wong | IVZ | Restricted Stock Units | Options Exercise | -51% | -31,955 | 30,687 | 28 Feb 2026 | Direct | ||
| Tony Wong | IVZ | Common Shares | Tax liability | -26.2% | -40,113 | 112,870 | 06 Feb 2026 | Direct |